FDA Approved: ONZETRA XSAIL — Supplemental Application (Currax Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved a supplemental application for ONZETRA XSAIL (sumatriptan succinate) filed by Currax Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• ONZETRA XSAIL (Sumatriptan succinate)

Snippet

SUPPL AP for ONZETRA XSAIL (SUMATRIPTAN SUCCINATE)